Gilead Sciences Inc.
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$2.8B
Focus Areas
4
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Arcus Biosciences | $2.8B |
| Asegua Therapeutics | — |
| Kite Pharma | — |
Biotech Investor · 3 portfolio companies
| Company | Valuation |
|---|---|
| Arcus Biosciences | $2.8B |
| Asegua Therapeutics | — |
| Kite Pharma | — |